December 5, 2021 2:01 am Published by admin – Orphan-drug designation follows fast track designation granted to INBRX-109 in conventional chondrosarcoma – Preliminary median progression-free survival (PFS) of 7.4 months and disease control rate of 89% observed in conventional chondrosarcoma patients in ongoing Phase 1 trial – Potential registration-enabling Phase 2 trial of INBRX-109 in conventional chondrosarcoma initiated in June 2021 SAN DIEGO, [...]
November 23, 2021 4:46 pm Published by admin View ORCID ProfileWilliam Cross, Iben Lyskjær, Tom Lesluyes, Steven Hargreaves, Anna-Christina Strobl, Christopher Davies, Sara Waise, Shadi Hames, Dahmane Oukrif, Hongtao Ye, Fernanda Amary, Roberto Tirabosco, Toby Baker, David Barnes, Christopher Steele, Ludmil Alexandrov, Gareth Bond, Genomics England Research Consortium, Paul Cool, Nischalan Pillay, Peter Van Loo, Adrienne M Flanagan doi: https://doi.org/10.1101/2021.11.02.21265785 Abstract The treatment [...]
November 22, 2021 4:38 pm Published by admin In our on-going effort to promote more research, clinical trials, improve treatment and seek a cure for Chondrosarcoma, the CS Foundation is in the process of establishing a contractual partnership with NORD: National Organization for Rare Disorders to create a Patient Registry/ Natural History Study exclusively for Chondrosarcoma Patients. Such a registry does not exist [...]
November 21, 2021 5:28 pm Published by admin by Lyubomir Haralambiev 1,2,*, Andreas Nitsch 1, Josephine M. Jacoby 1, Silas Strakeljahn 1, Sander Bekeschus 3, Alexander Mustea 4, Axel Ekkernkamp 1,2 and Matthias B. Stope 4 1 Department of Trauma, Reconstructive Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany 2 Department of Trauma and Orthopaedic Surgery, BG Klinikum Unfallkrankenhaus Berlin [...]
November 12, 2021 2:22 am Published by admin Rose Truong Paderanga Hi all- I was recently featured on the local news for the surgery for my chondrosarcoma and wanted to share… Medical advancements are happening all the time guys. Don’t give up hope. We’re in this together. YOUTUBE.COM
November 2, 2021 6:06 pm Published by admin Project ended 30 June 2020 Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape Town Email Title of the project TBX3 in combination with c-Myc and Nucleolin as multiple markers for the early detection of sarcomas. Project Description Sarcomas are highly diverse mesenchymal malignancies of the bone (osteosarcoma), blood vessels (angiosarcoma), [...]
November 1, 2021 4:40 pm Published by admin TBX3 in Combination with c-Myc and Nucleolin as Multiple Markers for the Early Detection of Sarcomas Project ended 30 June 2020 Prof Sharon Prince Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape Town Email Title of the project TBX3 in combination with c-Myc and Nucleolin as multiple markers for the [...]
October 14, 2021 2:26 pm Published by admin A research project funded by the Bone Cancer Research Trust has found a promising clinical biomarker that offers pathologists an accurate and reproducible test to diagnose and stage chondrosarcoma, informing clinical management and deciding the type of surgery a patient would need. This could also provide a non-invasive way to monitor patients and detect the [...]
October 12, 2021 1:40 am Published by admin NORD Offers Information and Support for Patients of Rare Cancers November 24, 2014 Peter L. Saltonstall CURE, Winter 2014, Volume 13, Issue 4 NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer. [...]
October 12, 2021 1:31 am Published by admin Saavan Patel 1, Ravi S Nunna 1, James S Ryoo 1, Darius Ansari 1, Nauman S Chaudhry 1, Ankit I Mehta 2 For more information: Outcomes and Patterns of Care in Adult Skull Base Chondrosarcoma Patients in the United States – PubMed (nih.gov) Abstract Background: Chondrosarcomas of the skull base are rare intracranial tumors of [...]
